In VTE at high risk for recurrence, reduced- vs. full-dose DOACs did not differ for symptomatic recurrence but reduced bleeding at 37 mo.

Bell, Conor; Carlin, Stephanie; ACP Journal Club Editorial Team at McMaster University · Ann Intern Med · 2025

Where this comes from

Record sourced from PubMed, PMID 40456157.
Also identified by DOI 10.7326/ANNALS-25-01856-JC.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text].

Read the full text

View on PubMed · Publisher (DOI)